Abstract
Intravascular lymphoma (IVL), a rare, extranodal form of non-Hodgkin lymphoma (NHL), can cause infarcts by occluding small arteries of the brain. Owing to its heterogeneous clinical manifestations and unfavorable prognosis, the diagnosis is often made postmortem. Patients can present with a range of motor or sensory deficits, rapid cognitive impairment, aphasia or signs of myelitis, often with nonspecific radiographic findings.Timely recognition of a treatable disease is essential to prevent permanent neurocognitive defects. We present a case who could be treated successfully with chemotherapy.
This is a preview of subscription content, log in via an institution to check access.
Access this article
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
References
Ponzoni M, Arrigoni G, Gould VE, et al. Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol. 2000;31:220–226.
Swerdlow SH, Campo E, Harris NL. et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. Lyon: IARC; 2008.
Zuckerman D, Seliem R, Hochberg E. Intravascular Lymphoma: the Oncologist’s “great imitator”. Oncologist. 2006;11:496–502.
Ferreri AJ, Campo E, Seymour JF, et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the “cutaneous variant”. Br J Haematol. 2004;127:173–183.
Shimada K, Kinoshita T, Naoe T, et al. Presentation and management of intravascular large B‑cell lymphoma. Lancet Oncol. 2009;10:895–902.
Beristain X, Azzarelli B. The neurological masquerade of intravascular lymphomatosis. Arch Neurol. 2002;59:439–443.
Heinrich A, Vogelgesang S, Kirsch M, et al. Intravascular lymphomatosis presenting as rapidly progressive dementia. Eur Neurol. 2005;54:55–58.
Murase T, Nakamura S, Kawauchi K, et al. An Asian variant of intravascular large B‑cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B‑cell lymphoma associated with haemo-phagocytic syndrome. Br J Haematol. 2000;111:826–834.
Pongpudpunth M, Rattanakaemakorn P, Fleischer A. Usefulness of random skin biopsy as a diagnostic tool of Intravascular Lymphoma presenting with fever of unknown origin. Am J Dermatopathol. 2015;37(9):686–690.
Shimada K, Matsue K, Yamamoto K, et al. Retrospective analysis of intravascular large B‑cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan. J Clin Oncol. 2008;26:3189–3195.
Shimada K, Murase T, Matsue K, et al. Central nervous system involvement in intravascular large B‑cell lymphoma: A retrospective analysis of 109 patients. Cancer Sci. 2010;101:1480–1486.
Sawada T, Omuro Y, Kobayashi T, et al. Long-term complete remission in a patient with intravascular large B‑cell lymphoma with central nervous system involvement. Onco Targets Ther. 2014;7:2133–2136.
Fonkern E, Lok E, Robison D, et al. The natural history of intravascular lymphomatosis. Cancer Med. 2014;3(4):1010–1024.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
S. Hofer, M. Kessler, J. Godau, D. Weiler, K. Frontzek, E. J. Rushing, and S. Aebi state that there are no conflicts of interest.
Additional information
S. Hofer and M. Kessler contributed equally to the manuscript.
Rights and permissions
About this article
Cite this article
Hofer, S., Kessler, M., Godau, J. et al. Intravascular large B‑cell lymphoma. memo 9, 59–62 (2016). https://doi.org/10.1007/s12254-016-0262-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12254-016-0262-8